Insider Transactions in Q1 2021 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
26,844
-21.91%
|
$2,415,960
$90.12 P/Share
|
|
Mar 30
2021
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Open market or private sale
|
Direct |
12,900
-7.9%
|
$1,096,500
$85.33 P/Share
|
|
Mar 10
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
66,730
+50.0%
|
-
|
|
Mar 10
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
66,730
-82.25%
|
-
|
|
Mar 01
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
26,975
-1.42%
|
$2,454,725
$91.64 P/Share
|
|
Mar 01
2021
|
Gino Santini Director |
SELL
Open market or private sale
|
Direct |
12,000
-33.52%
|
$1,092,000
$91.47 P/Share
|
|
Mar 01
2021
|
James Samuel Shannon Director |
SELL
Open market or private sale
|
Direct |
7,232
-100.0%
|
$658,112
$91.3 P/Share
|
|
Mar 01
2021
|
James Samuel Shannon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,232
+50.0%
|
$86,784
$12.19 P/Share
|
|
Feb 26
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
1,099
-1.26%
|
$100,009
$91.83 P/Share
|
|
Feb 24
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
15,944
-8.01%
|
$1,450,904
$91.1 P/Share
|
|
Feb 22
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Open market or private sale
|
Direct |
5,698
-3.28%
|
$495,726
$87.81 P/Share
|
|
Feb 22
2021
|
Vikram Karnani EVP & President, International |
SELL
Open market or private sale
|
Direct |
8,358
-3.74%
|
$727,146
$87.76 P/Share
|
|
Feb 21
2021
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
576
-1.24%
|
$50,688
$88.87 P/Share
|
|
Feb 21
2021
|
Daniel A. Camardo EVP and President, U.S. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+2.73%
|
-
|
|
Feb 21
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,082
-1.04%
|
$95,216
$88.87 P/Share
|
|
Feb 21
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,182
+2.05%
|
-
|
|
Feb 17
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,179
-0.44%
|
$363,573
$87.17 P/Share
|
|
Feb 17
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,433
+0.98%
|
-
|
|
Feb 17
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,045
-30.67%
|
$90,915
$87.17 P/Share
|
|
Feb 17
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+40.9%
|
-
|
|
Feb 17
2021
|
Geoffrey M. Curtis EVP, Corporate Affairs, CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-0.8%
|
$60,552
$87.17 P/Share
|
|
Feb 17
2021
|
Geoffrey M. Curtis EVP, Corporate Affairs, CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,571
+1.77%
|
-
|
|
Feb 17
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-0.56%
|
$60,552
$87.17 P/Share
|
|
Feb 17
2021
|
Brian K Beeler EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,571
+1.26%
|
-
|
|
Feb 17
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-0.51%
|
$75,777
$87.17 P/Share
|
|
Feb 17
2021
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+1.13%
|
-
|
|
Feb 17
2021
|
Vikram Karnani EVP & President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-0.77%
|
$75,777
$87.17 P/Share
|
|
Feb 17
2021
|
Vikram Karnani EVP & President, International |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+1.7%
|
-
|
|
Feb 17
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
975
-0.95%
|
$84,825
$87.17 P/Share
|
|
Feb 17
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+1.87%
|
-
|
|
Feb 17
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-1.08%
|
$75,777
$87.17 P/Share
|
|
Feb 17
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+2.37%
|
-
|
|
Feb 17
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-0.79%
|
$60,552
$87.17 P/Share
|
|
Feb 17
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Grant, award, or other acquisition
|
Direct |
1,571
+1.75%
|
-
|
|
Feb 17
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,045
-5.56%
|
$90,915
$87.17 P/Share
|
|
Feb 17
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+11.15%
|
-
|
|
Feb 17
2021
|
Jeff Kent Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-0.97%
|
$60,552
$87.17 P/Share
|
|
Feb 17
2021
|
Jeff Kent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,571
+2.14%
|
-
|
|
Feb 11
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
10,786
-9.63%
|
$970,740
$90.0 P/Share
|
|
Feb 02
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
4,530
-3.89%
|
$385,050
$85.0 P/Share
|
|
Feb 01
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Bona fide gift
|
Indirect |
3,094
+1.11%
|
-
|
|
Feb 01
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Direct |
3,094
-74.68%
|
-
|
|
Feb 01
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
2,950
-12.88%
|
$227,150
$77.04 P/Share
|
|
Feb 01
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,087
+28.41%
|
-
|
|
Jan 22
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
11,323
-0.59%
|
$860,548
$76.58 P/Share
|
|
Jan 22
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Open market or private sale
|
Direct |
2,226
-2.51%
|
$169,176
$76.81 P/Share
|
|
Jan 22
2021
|
Vikram Karnani EVP & President, International |
SELL
Open market or private sale
|
Direct |
2,731
-2.39%
|
$207,556
$76.81 P/Share
|
|
Jan 21
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
755
-5.18%
|
$58,135
$77.43 P/Share
|
|
Jan 21
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,575
+15.03%
|
-
|
|
Jan 21
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,007
-0.93%
|
$693,539
$77.43 P/Share
|